Price: $80.32
· 1 day: +3.81% · 5 days: +2.25% · 1 month: -5.36% · YTD: +10.01%
As of 2026-11-03 21:00 UTC.
52-week range: $65.04 – $128.45 (currently at 24% of the range).
MRCY is in a downtrend, momentum firm. $81.5 is the level overhead; $80 the first support below.
3 of 6 technical checks lean mixed.
| Trend | Downtrend · below 50-day & below 200-day |
|---|---|
| Momentum | RSI 59.49 · neutral · MACD bullish |
| Trend strength | ADX 21.1 · developing |
| Location | -1.4% vs 50-day MA |
| 52-week range | -36% from high · +21% from low |
| Volatility | ATR 3.56 · ~4.4%/day |
| Level | Type | Distance |
|---|---|---|
| $81.5 (resistance) | sma 50 | 1.47% |
| $89.99 (resistance) | swing zone | 12.04% |
| $91.39 (resistance) | sma 200 | 13.78% |
| $80.0 (support) | round | -0.4% |
| $78.21 (support) | swing zone | -2.63% |
| $73.38 (support) | swing zone | -8.64% |
| RSI (14) | 59.49 | MACD | -1.0617 |
|---|---|---|---|
| ADX (14) | 21.1 | ATR (14) | 3.56 |
| 50-day average | $81.5 | 200-day average | $91.39 |
Next earnings: 2026-11-10. MRCY earnings date, time and past reactions.
Report of 2026-10-28.
Mercury Systems (MRCY) has bounced 5.4% in five days, yet it remains in a weekly downtrend and trades at $78.55, below the $80 level where sellers have turned rallies back. The balance of evidence leans negative for the next two to six weeks, with medium conviction. The stock trails the S&P 500 over 50 days, and the daily trend runs with the weekly one. Earnings on November 10, 2026 are the next test.
No company news, analyst note or sector story is on file for MRCY this week, so the recent move has no stated cause. The stock closed down 1.5% on its latest session while the S&P 500 rose 0.6%. That makes the five-day gain look more like a trading bounce than a response to an event.
The attribution is plain. Over five days MRCY rose 5.4% and SPY rose 0.08%, so the market contributed almost nothing. No sector ETF figure is available, so the sector's share cannot be measured. What can be said is that the move was the stock's own, and it came after a one-month decline of 4.4%. The shares peaked at $84.87 on October 2, 2026 and now sit 7.4% below that close. The bounce has recovered part of that slide without reclaiming the 50-day average at $83.22.
With no articles to cite, there is no sourced debate to lay out, only the gap between price and analysts. Eleven analysts rate the stock a buy, with a mean price target of $110.36, a range of $78 to $130, and the stock 28.8% below the mean. That gap can be read two ways. Optimists see room to recover. Skeptics see targets that have not caught up with a stock that has fallen 37.8% from its 52-week high of $126.21. The lowest target, $78, is almost exactly where the stock trades, so even the most cautious analyst sees little downside from here. That sits awkwardly beside a chart showing sellers in control, and it is the main reason this note stops short of high conviction.
The long-term trend is down. The price is below its 40-week average and its 10-week average, and the 200-day average at $91.91 sits well above the 50-day at $83.22. The shares are 18.8% above the 52-week low of $66.12 but far below the high. The thesis is weakened rather than broken: the stock has not collapsed to new lows, but it has not shown the higher highs that would mark a recovery. The year-to-date gain of 7.6% is real, though it trails SPY's 12.9%. Over 200 days MRCY lags the index by 19.2 points. This looks like a stock in a long repair phase, not one in a clean new uptrend.
For the next two to six weeks, the balance of evidence leans negative, with medium conviction, 2 of 4 points. Two things support it. The daily trend runs with the weekly downtrend, so the short and long frames agree. And the stock has lagged the S&P 500 by 5.9% over 50 days, so buyers have not been paying up for it. Conviction is not higher because the other two points are missing: momentum is neutral, with RSI at 47, and the stock is not yet pressing the support below it.
The strongest case against this reading is the recent bounce itself. A 5.4% gain in five days while the market was flat is relative strength, and the consensus buy rating with a $110 mean target gives dip buyers something to point to. If the stock reclaimed $80 and then the 50-day average at $83.22, the downtrend would start to look like a base. It does not tip the balance because one strong week has not lifted the price above any major average, and the bounce stalled just under a level where sellers have appeared before.
The structure is below $80. The weekly trend is down, and $80 is a round number where sellers have shown up on rallies. Above it sit the 50-day average at $83.22 and then $89.99, a swing zone. A weekly close above $89.99 is where the downtrend would end, since that level sits just below the 200-day average at $91.91 and marks the top of the area the stock has failed to clear.
The breakout level on the downside is a daily close below $78.21, a swing-zone support just under the current price. From there the first target is $73.38, then $68.93, with $70 as a round-number pause between them. A move above $80.74, which is $80 plus a quarter of the 14-day average true range of $2.97, would show the breakdown was wrong. Measured against that stop, the first target pays 1.9 to 1 and the second 3.7 to 1, so the math reaches the 3 to 1 that makes a breakout worth the risk, but only at the second target.
A weekly close above $89.99 would change the picture. It would put the stock back above the swing zone that has capped it and close to the 200-day average, and it would be the first clear sign that buyers have taken control from sellers. The non-price fact most likely to do it is an earnings report on November 10, 2026 that moves analysts to defend their $110 mean target with better numbers. A weak report would more likely reinforce the weekly downtrend.
Interactive MRCY chart and analyst chat · Market terminal — movers, signals and news · Use MarketCrew inside Claude · Use MarketCrew inside ChatGPT · Top gainers today · 52-week highs